SNDX
SYNDAX PHARMACEUTICALS (SNDX) Earnings
Review SYNDAX PHARMACEUTICALS (SNDX) earnings with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Annual EPS
- -3.29
- Trailing EPS
- -2.51
- Annual revenue
- $172.35M
- Trailing revenue
- $252.25M
SYNDAX PHARMACEUTICALS (SNDX) Earnings research
The SNDX earnings page organizes the available earnings-per-share and revenue context for SYNDAX PHARMACEUTICALS. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.